Promega Corporation

High-Throughput Automation of Multiplexed Cell-Based Assays for Viability and Cytotoxicity

  • Share
  • Print
  • Email
  • Download PDF
  • Article
  • Comments & Ratings

Abstract

Here we demonstrate the use of the MultiTox Family of cytotoxicity assays in 1,536-well screening experiments and in multiplex with caspase assays in 384-well formats.

Cell Notes 20, 26–29.

Tracy Worzella1, Michael Busch2 and Andrew Niles1

1Promega Corporation, 2CYBIO, AG

Publication Date: 2008

Download Article (913 KB)

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.

Click Here for Technical Questions and Ordering Support »